Abstract
Summary: The basal and maximal gastric acid output were determined before and during maintenance therapy with long-acting parapenzolate bromide (Relanol) in 15 Chinese male subjects suffering from peptic ulceration. Statistical analysis of the results confirmed that there was significant suppression of both basal and maximal acid secretion by parapenzolate bromide. No untoward side effects, other than dryness of the mouth, were seen. It is concluded that parapenzolate bromide is a safe and effective anticholinergic drug.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
